Suchergebnisse

[2], 5, [1]; 13, [1] p. ; Concerning the Petition of Right. ; Imprint from STC. ; "Sir Henry Martins speech" (caption title) has separate pagination and register; text commences "My Lords, the worke of this day .". Variant: lacking this caption title. Certain parts of the text also show minor resetting. ; Reproduction of the original in the British Library.

"Taxpayers' meeting, October 22, 1877," [in New York City] tipped in, p. 45. ; Another edition printed as: New York (State) Legislature 1877. Assembly. Doc. 68. ; Also called: Tilden Commission. ; Series statement on electronic version: The Cornell Library New York State Historical Literature. ; Mode of access: Internet.

Children are the future of a country, and they should be at the center of the national development strategy and policies. However, these are also objects of vulnerability and abuse. Therefore, child protection and child-abuse prevention are the responsibilities of each country. In this article, the authors have mentioned and analyzed the following main issues: (i) The facts and the problem of child abuse in Vietnam; (ii) Causes of child abuse in Vietnam; (iii) Recommendations to improve laws and policies and the effectiveness of implementation of child abuse prevention and abatement in Vietnam.

Global commitments aim to provide antiretroviral therapy (ART) to 15 million people living with HIV by 2015, and recent studies have demonstrated the potential for widespread ART to prevent HIV transmission. Increasingly, countries are adapting their national guidelines to start ART earlier, for both clinical and preventive benefits. To maximize the benefits of ART in resource‐limited settings, six key principles need to guide ART choice: simplicity, tolerability and safety, durability, universal applicability, affordability and heat stability. Currently available drugs, combined with those in late‐stage clinical development, hold great promise to simplify treatment in the short term. Over the longer term, newer technologies, such as long‐acting formulations and nanotechnology, could radically alter the treatment paradigm. This commentary reviews recommendations made in an expert consultation on treatment scale up in resource‐limited settings.